Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin

Summary

The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.

Timeline

Start

2005-06

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped (Business): “Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue study of pharmacy-compounded drug.”

Drugs

Indications